QA: Biohaven Pharmaceutical Holding Co Ltd in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001689813_2022_Biohaven_Pharmaceutical_Holding_Co_Ltd.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001689813, Biohaven Pharmaceutical Holding Co Ltd

  xvar xval
0 AssetsCurrent 876,254,000
1 IntangibleAssetsNetIncludingGoodwill 56,438,000
2 PropertyPlantAndEquipmentNet 14,690,000
3 remainder_Assets 129,830,000
4 LiabilitiesCurrent 534,202,000
5 LiabilitiesNoncurrent 12,236,000
6 remainder_Liabilities 1,213,783,000
7 CostOfGoodsAndServicesSold 461,375,947
8 SellingGeneralAndAdministrativeExpense 1,045,815,593
9 ResearchAndDevelopmentExpense 637,001,529
10 remainder_Expenses 6,922,952
11 remainder_Revenues 2,456,441,919
12 remainder_NetIncome -148,298,725
13 remainder_ComprehensiveNetIncome 1,601,037
  yvar yval
0 Assets 1,077,212,000
1 Liabilities 1,760,221,000
2 Expenses 2,151,116,021
3 Revenues 2,456,441,919
4 StockholdersEquity -683,009,000
5 NetIncome 157,027,173
6 ComprehensiveNetIncome 157,827,692
7 BaseVar 3,797,445,351
8 EconomicCapitalRatiobeforeLimitedLiability -0.938
9 EconomicCapitalRatio 1.31

Edgar->Model Mapping

Feature Distribution

Change over Time